JUNO HEALTH PARTNERS WITH AVO TO INTEGRATE AI INTO ITS EHR SYSTEM
JUNO BEACH, Fla., March 3, 2025 /PRNewswire/ — Juno Health, a leader in healthcare innovation and digital transformation, is partnering with Avo, an AI-powered clinical decision support platform, to integrate AI scribe technology into its Juno EHR (electronic health record) systems. Juno Healt
NAMSA Completes Acquisition of WuXi AppTec US Medical Device Testing Business
TOLEDO, Ohio, March 3, 2025 /PRNewswire/ — NAMSA, a leading US based MedTech testing, clinical and regulatory consulting firm, announced that it finalized its acquisition of WuXi AppTec’s US medical device testing operations on February 28. The acquisition brings together two of the mo
Lunar Test Facility Arrives on Moon to Conduct Regolith Research
HOUSTON, March 3, 2025 /PRNewswire/ — Aegis Aerospace Inc. proudly celebrates the historic and successful arrival on the Moon of its first lunar test facility, RAC, aboard Firefly Aerospace’s Blue Ghost Mission 1 lunar lander. RAC will gather data on the Moon’s surface to test, imp
Fushi Deepens Its Reach across Southeast Asia, Leveraging AI to Drive SaaS Innovation
SINGAPORE, March 3, 2025 /PRNewswire/ — AI is no longer a distant vision. It has seamlessly integrated into our daily life and business operations, transforming industries at an unprecedented pace. Fushi Technology, an AI-powered, one-stop digital service provider for merchants, has launched i
Chord Energy Corporation Announces $750 Million Offering of Senior Notes
HOUSTON, Texas, March 3, 2025 /PRNewswire/ — Chord Energy Corporation (NASDAQ: CHRD) (the “Company,” “we,” “us,” or “our”), announced today that, subject to market conditions, it intends to offer $750 million in aggregate principal amount of seni
CHORD ENERGY CORPORATION ANNOUNCES A CASH TENDER OFFER FOR ANY AND ALL OF ITS OUTSTANDING 6.375% SENIOR NOTES DUE 2026
HOUSTON, Texas, March 3, 2025 /PRNewswire/ — Chord Energy Corporation (NASDAQ: CHRD) (the “Company,” “we,” “us,” or “our”), today announced that it has commenced a cash tender offer to purchase (the “Offer”) any and all of its outstan
In a turbulent world, the value of China’s two sessions gains increasing prominence: Global Times editorial
BEIJING, March 3, 2025 /PRNewswire/ — This week, China will enter the period of its annual “two sessions.” The third session of the 14th National People’s Congress (NPC) and the third session of the 14th National Committee of the Chinese People’s Political Consultative
New AI Agent Capabilities in Oracle Textura Help Accelerate Subcontractor Payments
Subcontractors can now receive real-time, personalized assistance with payment status, signing documents, and more, saving valuable time NASHVILLE, Tenn., March 3, 2025 /PRNewswire/ — Oracle Customer Edge Summit — Oracle today announced new AI agent capabilities embedded directly within
Summa Health and Clearsense Partner to Revitalize Data for Improved Outcomes
One of Ohio’s largest integrated health systems deploys the 1Clearsense Platform to create a longitudinal EHR, enabling comprehensive access to legacy data for better clinical decision-making and enhanced operational efficiency NASHVILLE, Tenn., March 3, 2025 /PRNewswire/ — Clearsense®,
Latigo Biotherapeutics Granted FDA Fast Track Designation for LTG-001, Potential Best-in-Class Nav1.8 Inhibitor for the Non-Opioid Treatment of Acute Pain
LTG-001 demonstrated favorable safety and tolerability profile with predictable pharmacokinetics in Phase 1 trial Fast Track designation will facilitate development and expedited regulatory review of LTG-001 THOUSAND OAKS, Calif., March 3, 2025 /PRNewswire/ — Latigo Biotherapeutics (“La
